Latham & Watkins Advises Guardant Health in Pricing of Upsized Public Offering of Common Stock. Guardant Health, Inc., a leading precision oncology company, has announced the pricing...
Guardant Health’s Upsized Public Offering of Common Stock
Ironwood Pharmaceuticals’ $1 Billion Acquisition of VectivBio Holding
Advestra and Latham & Watkins advise Ironwood. Homburger AG serves as legal and tax advisor to VectivBio on the transaction. Goodwin advises Centerview Partners. VectivBio Holding...
4D Molecular Therapeutics’ $120 Million Common Stock Offering
Latham & Watkins advised 4D Molecular Therapeutics, while Cooley advised the underwriters for the offering. 4D Molecular Therapeutics, Inc. has announced that it priced an upsized...
Vaxcyte’s $500 Million Public Offering
Cooley advises Vaxcyte on the offering, and Latham & Watkins advises the underwriters. Vaxcyte, Inc. (Nasdaq: PCVX) has announced the pricing of an underwritten public offering...
Merck’s Acquisition of Prometheus Biosciences
Paul, Weiss, Rifkind, Wharton & Garrison represented Merck, Latham & Watkins represented Prometheus, Skadden represented the financial advisors on the deal. Prometheus Biosciences, Inc. have entered...
Mineralys Therapeutics’ $192 Million Initial Public Offering
Latham & Watkins advised Mineralys Therapeutics, and Shearman & Sterling advised the underwriters. Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced the pricing of its upsized initial public...
Bausch + Lomb’s Acquisition of AcuFocus
Latham & Watkins LLP represented AcuFocus in the transaction. Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see...
Alphatec Spine’s $200 Million Growth Financing Facilities
Latham & Watkins LLP represented Alphatec in the transactions. Alphatec Holdings, Inc. (Nasdaq: ATEC), a medical technology company focusing on surgical treatment for spinal disorders has...
Geron Corporation’s $198 Million Upsized Public Offering
Cooley advised Geron, while Latham & Watkins represented the underwriters in the offering. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, has announced the pricing...
Infrared Cameras Holdings’ Merger With SportsMap Tech Acquisition Corp.
Latham & Watkins advised Infrared Cameras, while ArentFox Schiff advised SportsMap on the deal. Infrared Cameras Holdings, Inc., a leading provider of intelligent thermal imaging platforms,...
Kindeva Drug Delivery’s Combination With Meridian Medical Technologies
Kirkland & Ellis and ArentFox Schiff advised Altaris on the deal. Latham & Watkins represented the lenders on the financing aspects. Altaris, LLC, a healthcare investment...
Kura Oncology’s $125 Million Financing Agreement
Latham & Watkins LLP represented Hercules Capital, Inc. in the transaction. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...